BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Larijani B, Goodarzi P, Sheikh Hosseini M, M. Nejad S, Alavi-moghadam S, Sarvari M, Abedi M, Arabi M, Rahim F, Foroughi Heravani N, Hadavandkhani M, Payab M. OMICs Profiling of Cancer Cells. In: Arjmand B, editor. Genomics, Proteomics, and Metabolomics. Cham: Springer International Publishing; 2019. pp. 141-57. [DOI: 10.1007/978-3-030-27727-7_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Mehrabi SF, Ghatak S, Mehdawi LM, Topi G, Satapathy SR, Sjölander A. Brain-Derived Neurotrophic Factor, Neutrophils and Cysteinyl Leukotriene Receptor 1 as Potential Prognostic Biomarkers for Patients with Colon Cancer. Cancers (Basel) 2021;13:5520. [PMID: 34771682 DOI: 10.3390/cancers13215520] [Reference Citation Analysis]
3 Wong YK, Tse HF. Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease. Front Cardiovasc Med 2021;8:713191. [PMID: 34660715 DOI: 10.3389/fcvm.2021.713191] [Reference Citation Analysis]
4 Zhang C, Jing LW, Li ZT, Chang ZW, Liu H, Zhang QM, Zhang QY. Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis. Biosci Rep 2019;39:BSR20182179. [PMID: 30971501 DOI: 10.1042/BSR20182179] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Chen W, Zhang W, Wu R, Cai Y, Xue X, Cheng J. Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis. Oncol Lett 2019;18:5499-507. [PMID: 31612058 DOI: 10.3892/ol.2019.10869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peng W, Liu YN, Zhu SQ, Li WQ, Guo FC. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer. Cancer Med 2018;7:3773-91. [PMID: 30003708 DOI: 10.1002/cam4.1618] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Balber T, Tran L, Benčurová K, Raitanen J, Egger G, Mitterhauser M. Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals 2022;15:227. [DOI: 10.3390/ph15020227] [Reference Citation Analysis]
8 Nakamura S, Kanda M, Kodera Y. Incorporating molecular biomarkers into clinical practice for gastric cancer. Expert Rev Anticancer Ther 2019;19:757-71. [PMID: 31437076 DOI: 10.1080/14737140.2019.1659136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Zhang F, Li K, Pan M, Li W, Wu J, Li M, Zhao L, Wang H. miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop. J Exp Clin Cancer Res 2018;37:152. [PMID: 30012200 DOI: 10.1186/s13046-018-0821-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
10 Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
11 Beyer K, Moris L, Lardas M, Haire A, Barletta F, Scuderi S, Vradi E, Gandaglia G, Omar MI, MacLennan S, Zong J, Farahmand B, Maclennan SJ, Devecseri Z, Asiimwe A, Collette L, Bjartell A, Ndow J, Briganti A, Van Hemelrijck M; PIONEER Consortium. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol. BMJ Open 2021;11:e040531. [PMID: 33574142 DOI: 10.1136/bmjopen-2020-040531] [Reference Citation Analysis]
12 Palstrøm NB, Matthiesen R, Rasmussen LM, Beck HC. Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research. Biomedicines 2022;10:162. [DOI: 10.3390/biomedicines10010162] [Reference Citation Analysis]
13 Baatar S, Bai T, Yokobori T, Gombodorj N, Nakazawa N, Ubukata Y, Kimura A, Kogure N, Sano A, Sohda M, Sakai M, Tumenjargal A, Ogata K, Kuwano H, Shirabe K, Saeki H. High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer. Ann Surg Oncol 2020;27:4360-8. [PMID: 32356270 DOI: 10.1245/s10434-020-08518-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Liu J, Chen Z, Li Y, Zhao W, Wu J, Zhang Z. PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Front Pharmacol 2021;12:731798. [PMID: 34539412 DOI: 10.3389/fphar.2021.731798] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wangxia LV, Fang Y, Liu Y, Zhao Y, Shi Z, Zhong H. Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells. Saudi J Gastroenterol. 2019;25:119-125. [PMID: 30719998 DOI: 10.4103/sjg.sjg_283_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 [PMID: 33033565 DOI: 10.4254/wjh.v12.i9.558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Shoeibi S. Diagnostic and theranostic microRNAs in the pathogenesis of atherosclerosis. Acta Physiol (Oxf) 2020;228:e13353. [PMID: 31344321 DOI: 10.1111/apha.13353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
18 Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer. Cancers (Basel) 2021;13:4455. [PMID: 34503265 DOI: 10.3390/cancers13174455] [Reference Citation Analysis]
19 Bermúdez A, Arranz-Salas I, Mercado S, López-Villodres JA, González V, Ríus F, Ortega MV, Alba C, Hierro I, Bermúdez D. Her2-Positive and Microsatellite Instability Status in Gastric Cancer-Clinicopathological Implications. Diagnostics (Basel) 2021;11:944. [PMID: 34070574 DOI: 10.3390/diagnostics11060944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Peluso G, Incollingo P, Campanile S, Menkulazi M, Scotti A, Tammaro V, Calogero A, Dodaro C, Carlomagno N, Santangelo ML. Relation Between Wound Complication and Lymphocele After Kidney Transplantation: A Monocentric Study. Transplant Proc 2020;52:1562-5. [PMID: 32299707 DOI: 10.1016/j.transproceed.2020.02.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chiu CT, Wang PW, Asare-Werehene M, Tsang BK, Shieh DB. Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand. Cancers (Basel) 2020;12:E1569. [PMID: 32545773 DOI: 10.3390/cancers12061569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Wang L, Du WQ, Xie M, Liu MR, Huo FC, Yang J, Pei DS. Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF. Gastric Cancer 2020;23:1003-17. [PMID: 32458234 DOI: 10.1007/s10120-020-01087-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cardoso AL, Fernandes A, Aguilar-pimentel JA, de Angelis MH, Guedes JR, Brito MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, Schosserer M, Grillari J, Peterson P, Tuna BG, Dogan S, Meyer A, van Os R, Trendelenburg A. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Research Reviews 2018;47:214-77. [DOI: 10.1016/j.arr.2018.07.004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 31.8] [Reference Citation Analysis]
24 Smith BJ, Silva-Costa LC, Martins-de-Souza D. Human disease biomarker panels through systems biology. Biophys Rev 2021;13:1179-90. [PMID: 35059036 DOI: 10.1007/s12551-021-00849-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 De Mello RA, Castelo-branco L, Castelo-branco P, Pozza DH, Vermeulen L, Palacio S, Salzberg M, Lockhart AC. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies? American Society of Clinical Oncology Educational Book 2018. [DOI: 10.1200/edbk_198805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kim BR, Jeong YA, Kim DY, Kim JL, Jeong S, Na YJ, Yun HK, Park SH, Jo MJ, Ashktorab H, Smoot DT, Lee DH, Oh SC. Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer. J Cancer 2020;11:460-7. [PMID: 31897241 DOI: 10.7150/jca.34773] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 de Assumpção PP, Khayat AS, Thomaz Araújo TM, Barra WF, Ishak G, Cruz Ramos AMP, Dos Santos SEB, Dos Santos ÂKCR, Demachki S, de Assumpção PB, Calcagno DQ, Dos Santos NPC, de Assumpção MB, Moreira FC, Dos Santos AMR, de Assumpção CB, Riggins GJ, Rodríguez Burbano RM. Traps and trumps from adjacent-to-tumor samples in gastric cancer research. Chin J Cancer Res 2018;30:564-7. [PMID: 30510368 DOI: 10.21147/j.issn.1000-9604.2018.05.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Shah A, Rauth S, Aithal A, Kaur S, Ganguly K, Orzechowski C, Varshney GC, Jain M, Batra SK. The Current Landscape of Antibody-based Therapies in Solid Malignancies. Theranostics 2021;11:1493-512. [PMID: 33391547 DOI: 10.7150/thno.52614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhang H, Song H, Yuan R, Zhang X, Yu H, Zhao Y, Jiang T. Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells. Biochem Biophys Res Commun 2018;497:108-14. [PMID: 29421658 DOI: 10.1016/j.bbrc.2018.02.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Kim W, Kim SJ. Heat Shock Factor 1 as a Prognostic and Diagnostic Biomarker of Gastric Cancer. Biomedicines 2021;9:586. [PMID: 34064083 DOI: 10.3390/biomedicines9060586] [Reference Citation Analysis]
31 Petersen EV, Chudakova DA, Skorova EY, Anikin V, Reshetov IV, Mynbaev OA. The Extracellular Matrix-Derived Biomarkers for Diagnosis, Prognosis, and Personalized Therapy of Malignant Tumors. Front Oncol 2020;10:575569. [PMID: 33425730 DOI: 10.3389/fonc.2020.575569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci 2019;6:91. [PMID: 31750312 DOI: 10.3389/fmolb.2019.00091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
33 Yörüker EE, Keskin M, Kulle CB, Holdenrieder S, Gezer U. Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer. Biomed Rep 2018;9:181-6. [PMID: 30083318 DOI: 10.3892/br.2018.1116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
34 Hu G, Lv Q, Yan J, Chen L, Du J, Zhao K, Xu W. MicroRNA-17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta-analysis, and bioinformatics. FEBS Open Bio 2018;8:1508-23. [PMID: 30186751 DOI: 10.1002/2211-5463.12496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Jia Y, Zhao LM, Bai HY, Zhang C, Dai SL, Lv HL, Shan BE. The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer. Biosci Rep 2019;39:BSR20181556. [PMID: 30530570 DOI: 10.1042/BSR20181556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Gallo M, Ferrara L, Calogero A, Montesano D, Naviglio D. Relationships between food and diseases: What to know to ensure food safety. Food Research International 2020;137:109414. [DOI: 10.1016/j.foodres.2020.109414] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
37 Guo J, Li X, Miao L, Sun H, Gao X, Guo S, Zhang Y, Cong P, Chen W. High-Throughput Sequencing Reveals the Differential MicroRNA Expression Profiles of Human Gastric Cancer SGC7901 Cell Xenograft Nude Mouse Models Treated with Traditional Chinese Medicine Si Jun Zi Tang Decoction. Evid Based Complement Alternat Med 2021;2021:6119212. [PMID: 34457026 DOI: 10.1155/2021/6119212] [Reference Citation Analysis]
38 Erabi H, Okada G, Shibasaki C, Setoyama D, Kang D, Takamura M, Yoshino A, Fuchikami M, Kurata A, Kato TA, Yamawaki S, Okamoto Y. Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis. Sci Rep 2020;10:16822. [PMID: 33033336 DOI: 10.1038/s41598-020-73918-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
39 Zubor P, Dankova Z, Kolkova Z, Holubekova V, Brany D, Mersakova S, Samec M, Liskova A, Koklesova L, Kubatka P, Bujnak J, Kajo K, Mlyncek M, Giordano FA, Golubnitschaja O. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare. Cancers (Basel) 2020;12:E1292. [PMID: 32443784 DOI: 10.3390/cancers12051292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]